Maven VCTs backs BioAscent with GBP1.6m investment
UK private equity house Maven Capital Partners (Maven) has completed a GBP1.6 million investment in BioAscent Discovery Limited (BioAscent), an integrated drug discovery services business. The funding will enable BioAscent to significantly expand its service offering, adding complementary chemistry and biology services and capitalise on the growing trend towards the
